Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LifeMD vs Omada Health

LifeMD
Graded #390

Higher grade

vs+2.1999999999999957
Omada Health
Graded #435

Lower grade

The verdict

LifeMD takes it — 57.8/100 to 55.6/100.

LifeMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publicly traded telehealth provider offering brand-name GLP-1 medications only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOmada Health +19
26
45
Dose & formulationLifeMD +24
64
40
Clinical oversightLifeMD +5
82
77
Labs & monitoringOmada Health +8
53
61
FulfillmentLifeMD +19
81
62
Contract termsEven
55
55
LifeMD · left barOmada Health · right bar

The numbers

MetricLifeMDOmada Health
WeighScore57.8/10055.6/100
GradeCC
Scorecard rank#390#435
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
LifeMD

Graded #390 · C

Strengths

  • Telehealth convenience
  • Physician-supervised program

Where it loses points

  • Brand-name GLP-1 only — no lower-cost compounded option
  • Monthly program & provider fee ($149/mo, $75 first month) is separate from medication cost
Omada Health

Graded #435 · C

Strengths

  • Added GLP-1 prescribing and medication management in late 2025
  • Clinicians trained in obesity care, available in all 50 states
  • Behavioral support wrapped before, during and after treatment
  • GLP-1 Flex Care adds a cash-pay medication pathway in 2026
  • Publicly traded, evidence-based virtual care platform

Where it loses points

  • Core program distributed via employers and health plans, limited cash-pay
  • GLP-1 prescribing is a recent addition still scaling
  • GLP-1 Flex Care only rolling out to employers later in 2026
  • No transparent published price for the core member program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard